Role of Lysophosphatidylcholine (LPC) in Atherosclerosis

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|14|30|3209-3220

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.14, Iss.30, 2007-12, pp. : 3209-3220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The role of interleukin 35 in atherosclerosis

By  

Current Pharmaceutical Design, Vol. 21, Iss. 35, 2015-10 ,pp. : 5151-5159

Bentham Science Publishers

Access to resources Recommend Favorite

Pathophysiology of Atherosclerosis: The Role of Inflammation

By  

Current Pharmaceutical Design, Vol. 17, Iss. 37, 2011-12 ,pp. : 4089-4110

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Micronutrients on Subclinical Atherosclerosis Micronutrients in Subclinical Atherosclerosis

By  

Current Pharmaceutical Design, Vol. 22, Iss. 2, 2016-01 ,pp. : 221-229

Bentham Science Publishers

Access to resources Recommend Favorite

The potential role of IL-37 in atherosclerosis

By Wu Bang-Wei   Zeng Qiu-Tang   Meng Kai   Ji Qing-Wei  

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 11, 2013-11 ,pp. : 857-860

Govi-Verlag

Access to resources Recommend Favorite

Apoptosis and Atherosclerosis: The Role of Nitric Oxide

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 5, Iss. 1, 2006-02 ,pp. : 27-33

Bentham Science Publishers

Access to resources Recommend Favorite